Wells Fargo & Company HAEMONETICS CORP MASS Transaction History

Wells Fargo & Company

1,776,000

Previous 2,017,000 11.95%

Previous $0 NaN%

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	N/A	-241,000 Reduced 11.95%	1,776,000 $0
Q4 2024 Feb 12, 2025	SELL	N/A	-6,248,000 Reduced 75.6%	2,017,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-5,618,000 Reduced 40.47%	8,265,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-3,235,000 Reduced 18.9%	13,883,000 $0
Q1 2024 May 10, 2024	SELL	N/A	-2,443,000 Reduced 12.49%	17,118,000 $0
Q4 2023 Feb 09, 2024	BUY	N/A	498,000 Added 2.61%	19,561,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	2,499,000 Added 15.09%	19,063,000 $0
Q2 2023 Aug 15, 2023	BUY	N/A	6,433,000 Added 63.5%	16,564,000 $0
Q1 2023 May 12, 2023	BUY	N/A	2,747,000 Added 37.2%	10,131,000 $0
Q4 2022 Feb 13, 2023	BUY	N/A	125,000 Added 1.72%	7,384,000 $0
Q2 2022 Aug 12, 2022	BUY	N/A	7,144,000 Added 6212.17%	7,259,000 $5.75 Million
Q1 2022 May 16, 2022	BUY	N/A	115,000 New	115,000 $98,000

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.